Skip to content

Earnings yield at other companies

Eli Lilly logo
Eli LillyLLY
3.1%+1.6pp
Pfizer logo
PfizerPFE
6.8%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
3.8%
Collegium Pharmaceutical, Inc. logo
Collegium Pharmaceutical, Inc.COLL
7.1%+2.6pp
Bioventus logo
BioventusBVS
4.6%+3.0pp
Avanos Medical logo
Avanos MedicalAVNS
-11.4%-5.1pp

Other financials

Income statement

See full
Operating income-$5.1M-14.6%
Net income-$5.0M+54.4%
EPS (diluted)-$0.15+98.2%

Balance sheet

See full
Cash & equivalents$13.2M-24.6%
Total debt$144.9K-24.2%
Total equity$80.6M+1,038%
Total assets$95.2M-1.8%

Cash flow

See full
Operating cash flow-$4.6M+2.0%

Valuation

See full
Market cap$54.14M-57.6%
Enterprise value$41.06M-64.7%

Returns & leverage

See full
Return on equity-64.6%-29.8pp
Debt / equity0.0×
Current ratio5.9×-1.6×

Where this comes from

Calculated from Dogwood Therapeutics’s reported figures.

Based on trailing twelve months.

The official record: Dogwood Therapeutics’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dogwood Therapeutics's earnings yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dogwood Therapeutics's earnings yield?
Dogwood Therapeutics (DWTX) reported earnings yield of -40.2% in Q1 2026.
How has Dogwood Therapeutics's earnings yield changed year-over-year?
Dogwood Therapeutics's earnings yield decreased by 126.9% year-over-year, from -17.7% to -40.2%.
What does earnings yield mean?
Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.